CDK1/Cyc B-IN-1

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

CDK1/Cyc B-IN-1 

CDK1/Cyc B-IN-1 (Compound 5) 是一种选择性的 CDK1/Cyc B 复合体抑制剂，IC50 为 97 nM。CDK1/Cyc B-IN-1 诱导细胞凋亡 (apoptosis) 和 G2/M 细胞期阻滞。CDK1/Cyc B-IN-1 对癌细胞具有广谱的细胞毒性。

CDK1/Cyc B-IN-1

CDK1/Cyc B-IN-1 Chemical Structure

CAS No. : 2459916-56-2

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

CDK1/Cyc B-IN-1 (Compound 5) is a selective CDK1/Cyc B complex inhibitor with an IC50 of 97 nM. CDK1/Cyc B-IN-1 triggers apoptosis and G2/M cell cycle arrest. CDK1/Cyc B-IN-1 shows broad-spectrum cytotoxic action against cancer cell lines[1].

IC50 & Target

CDK1-Cyclin B

97 nM (IC50)

体外研究
(In Vitro)

CDK1/Cyc B-IN-1 (Compound 5) shows cytotoxic activity with IC50 values of 5.33 ± 0.69 µM and 21.69 ± 1.04 µM against HCT-116 and WI-38, respectively[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

353.85

Formula

C14H12ClN3O2S2
CAS 号

2459916-56-2
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Mohamed SH, et al. An investigative study of antitumor properties of a novel thiazolo[4,5-d]pyrimidine small molecule revealing superior antitumor activity with CDK1 selectivity and potent pro-apoptotic properties. Bioorg Med Chem. 2020 Sep 1;28(17):115633.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务